MAPK3 and diabetes mellitus: The fact that diabetes-induced elevation in ROCK expression and phosphorylation at Y256 as well as ERK1/2 phosphorylation were markedly attenuated by chronic treatment with AG825 (Figure 3A) supported our assertion that ErbB2 is an upstream effector of ERK1/2 and ROCKs in mediating vascular dysfunction in diabetes.